Stay updated on LN-144 in Metastatic Uveal Melanoma Clinical Trial
Sign up to get notified when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.

Latest updates to the LN-144 in Metastatic Uveal Melanoma Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedRevision tag updated from v3.6.3 to v3.6.4 reflects a deployment-level update; the change is limited to metadata and does not alter study details or displayed content.SummaryDifference0.1%

- Check15 days agoChange DetectedThe study title and related eligibility text now include angiosarcoma, and the contact person has been updated; the enrollment target and Lifileucel/TIL treatment details have been revised to reflect the new protocol and sites.SummaryDifference2%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedFooter status shows a new Revision tag (v3.6.3) replacing the previous v3.6.2, representing a minor update to the page version.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a software update to the interface.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page gains new navigation/help sections (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study) and standardizes the Intervention/Treatment label. The revision note updates to v3.6.0, replacing the previous v3.5.5.SummaryDifference0.5%

- Check58 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating a minor version update. This reflects an updated page version rather than changes to the study information.SummaryDifference0.1%

Stay in the know with updates to LN-144 in Metastatic Uveal Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LN-144 in Metastatic Uveal Melanoma Clinical Trial page.